Human clinical study confirms that intake of alginate suppresses dietary salt absorption

Toy Medical Co., Ltd.
Human clinical study confirms that intake of alginate suppresses dietary salt absorption

Toy Medical Co., Ltd. (Headquarters: Kamimashiki-gun, Kumamoto Prefecture; President: Hidenori Takeshita) has confirmed in human clinical trials that intake of alginate suppresses the absorption of salt (sodium) from meals. A paper on this result was published in “Pharmacology and Therapy (2022, Vol. 50, No. 10, 1829-1836)”. Inhibitory effect of sodium absorption by intake of
alginate-containing supplements
―A placebo-controlled, randomized, double-blind, crossover study― Authors: Takamasa Masuda1, Akiko Okamura1, Kosei Nishikawa1, Hirohito Nishikawa1, Junichi Yatabe2, Yuya Hayashi3, Hidenori Takeshita3 1Healthcare Systems Co., Ltd., 2Telemedis Association, 3Toy Medical Co., Ltd. Source: Pharmacology and Therapeutics, Volume 50, Issue 10, 1829-1836 (2022). Publisher: Life Science Publishing
For details, please check the Toy Medical Co., Ltd. website. http://www.toymedical.jp/news/
◆Company overview
Company name: Toy Medical Co., Ltd.
Business description: Development and sales of medical equipment, health foods, and beauty products
Date of establishment: October 9, 2013
Location: 750-1 Toyoaki, Mifune-cho, Kamimashiki-gun, Kumamoto Prefecture Representative: Hidenori Takeshita
Capital: 100 million yen
Website: http://www.toymedical.jp/
Details about this release:
https://prtimes.jp/main/html/rd/p/000000015.000063699.html


rehow

Leave a Reply

Your email address will not be published.

%d bloggers like this: